Future Medicine Co., Ltd. (XKON:341170)
South Korea · Delayed Price · Currency is KRW 1,848.00
+61.00 (3.41%)
At close: Jul 31, 2025
Future Medicine Company Description
Future Medicine Co., Ltd. operates as a drug development company worldwide.
It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy.
The company was founded in 2015 and is based in Seongnam, South Korea.
Future Medicine Co., Ltd.
| Country | South Korea |
| Founded | 2015 |
| Industry | Pharmaceutical Preparations |
| Employees | 26 |
Contact Details
Address: Rm 616 LH-Business Growth Center Seongnam, 13449 South Korea | |
| Phone | 82 2 3429 3473 |
| Website | futuremedicine.co.kr |
Stock Details
| Ticker Symbol | 341170 |
| Exchange | Korea New Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2834 |